Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Diego Villa Clé, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01297972
First received: February 16, 2011
Last updated: February 2, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)